This is called, aptly, obstructive hypertrophic cardiomyopathy. This kind of obstruction is behind many of the more ...

Diagnosis requires left ventricular regional wall motion abnormalities that extend beyond a single coronary artery distribution in the absence of obstructive coronary artery disease. Approximately ...

Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Capricor Therapeutics (CAPR – Research Report). The ...

With the recipient facing extreme breathing difficulty, a heart transplant was the only option left. While his family waited ...

杨仲豪指出，心碎症候群特别好发于女性族群，且以更年期中、后尤为严重。值得注意的是女性以情绪压力诱发导致为主，男性则以生理压力为主，虽然心碎症候群并非实际上心臟会碎裂成一块块的样子，但对某些人来说，或许他们真的经歷了那样撕心裂肺的剧痛。

Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a ...

Rep. Frank Pallone (D-Long Branch)’s Cardiomyopathy Health, Education, Awareness, Research, and Training in Schools (HEARTS) ...

杨仲豪指出，心碎症候群特别好发于女性族群，且以更年期中、后尤为严重。值得注意的是女性以情绪压力诱发导致为主，男性则以生理压力为主，虽然心碎症候群并非实际上心臟会碎裂成一块块的样子，但对某些人来说，或许他们真的经歷了那样撕心裂肺的剧痛。

Better imaging parameters may exist for risk stratification in nonischemic dilated cardiomyopathy (NIDCM), based on a ...

Discover BridgeBio Pharma's groundbreaking patent for treating ATTR cardiomyopathy with Compound 1, showcasing improved patient outcomes and reduced mortality rates.

Edgewise Therapeutics stock skyrocketed on Thursday after a single dose of its drug improved heart function in cardiomyopathy patients. Edgewise stock soars on positive data from an early-stage study ...